drugset / Trial / NCT07524959
Antagonism of Neostigmine in Continuous Infusion of Mivacurium
RandomizedParallel-groupDouble-blindPrevention
Summary
In this study, the antagonism of neostigmine, a cholinesterase inhibitor, on continuous infusion of mivacurium during foot and ankle surgery under general anesthesia was investigated, and the appropriate time point of antagonism was explored.
Timeline
- Start
- 2026-05-01
- Primary completion
- 2026-07-20
- Completion
- 2026-07-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neostigmine | Other / unclassified | 0.04 mg/kg | — |
| Background | Atropine | Other / unclassified | 0.02 mg/kg | — |
Indications
No indication recorded.